Breast cancer is the most relevant cancer in women worldwide. It is the second most frequently diagnosed cancer (after lung cancer) and the first leading cause of cancer-related death in women, being the fourth globally regardless of gender. By 2040, breast cancer is predicted to increase to over 3 million new cases and 1 million […]
This webinar will explore state-of-the-art AI approaches for advancing neuroimaging, with a particular focus on quantitative PET. It will cover the entire imaging pipeline, from preprocessing, acquisition, and tomographic reconstruction to quantification, segmentation, denoising, and resolution enhancement, demonstrating how modern AI can enable more reproducible and robust brain PET biomarkers. Through two expert presentations and practical case […]
This course provides a comprehensive update on instrumental and radiopharmaceutical innovations in the diagnosis and treatment of neuroblastoma. Participants will explore current and emerging imaging modalities, with a comparative analysis of MIBG, MFBF, FDOPA, and Gallium-based tracers, highlighting their evolving roles in staging, risk stratification, and response assessment. The course will address recent changes in […]
This webinar will be on the future of cancer staging with hybrid imaging technologies. Participants will gain an overview of advanced PET/CT, SPECT/CT, and PET/MRI systems, learning how hybrid imaging enhances diagnostic accuracy and supports more precise clinical decisions.The session will explore the practical challenges technologists face when working with these cutting-edge systems, including image […]
More info will come soon Learning Objectives Target Audience Faculty Event Overview
This intensive 1,5-day course bridges the gap between radiobiology, dosimetry, and clinical practice in targeted radionuclide therapy. Designed for early-career nuclear medicine physicians and medical physicists, the programme explores dose-response relationships in the three most commonly used theranostic molecules: somatostatin-ligands for neuroendocrine tumours, PSMA-inhibitors for prostate cancer, and radioiodine for thyroid malignancies. Through a balanced […]
More info will come soon Learning Objectives Target Audience Faculty Event Overview
More info will come soon Learning Objectives Target Audience Faculty Event Overview
This 1,5-day course focuses on the growing field of integrated imaging in infectious and inflammatory diseases in children, with an emphasis on hybrid imaging. The panelists will introduce the participants to the specific aspects of paediatric patients in this growing field, covering the most relevant topics of the clinical scenario and the technical options available […]
More info will come soon Learning Objectives Target Audience Faculty Event Overview
More info will come soon Learning Objectives Target Audience Faculty Event Overview
More information will come soon. Learning Objectives More info will come soon. Target Audience More info will come soon. Faculty Registration Details
European School of Multimodality Imaging & Therapy (ESMIT)
Schmalzhofgasse 26
1060 Vienna
Austria
phone +43 1 890 44 27
e-mail esmit@eanm.org
